(2S)-2-[[(4-nitrophenoxy)-phenoxyphosphoryl]amino]propanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-2-[[(4-nitrophenoxy)-phenoxyphosphoryl]amino]propanoic acid
• 化学式: C15H15N2O7P
• 分子量: 366.26
• InChiKey: BQBSLSLGCYRCSB-FAPJJIHTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  131
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• CYCLOPENTENYL PURINE DERIVATIVE OR SALT THEREOF
  申请人：Fujifilm Corporation

  公开号：US20210155644A1

  公开（公告）日：2021-05-27

  An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides an anti-adenoviral agent including a compound represented by General Formula [1] (in the formula, R 1 represents a hydrogen atom, a halogen atom, an amino group which may be substituted, a monocyclic nitrogen-containing heterocyclic ring group which may be substituted (provided that a nitrogen atom forming the ring is bonded to a carbon atom to which R 1 is bonded), a monocyclic nitrogen- and oxygen-containing heterocyclic ring group which may be substituted (provided that a nitrogen atom forming the ring is bonded to a carbon atom to which R 1 is bonded), a C 1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R 2 represents a hydrogen atom or an amino protecting group; R 3 represents a C 1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R 4 represents a C 1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; and X represents an oxygen atom or a sulfur atom) or a salt thereof.

  本发明的一个目的是提供一种作为抗腺病毒药剂具有优异药效的化合物，以及一种抗腺病毒药剂。本发明提供了一种包括由通式[1]表示的化合物的抗腺病毒药剂 （在公式中，R 1 表示氢原子、卤素原子、可能被取代的氨基、可能被取代的单环氮含杂环基团（前提是形成环的氮原子与R 1 结合的碳原子相结合）、可能被取代的单环氮和氧含杂环基团（前提是形成环的氮原子与R 1 结合的碳原子相结合）、可能被取代的C 1-6 烷氧基、可能被保护的羟基等；R 2 表示氢原子或氨基保护基团；R 3 表示可能被取代的C 1-20 烷氧基、可能被取代的芳氧基、可能被取代的氨基等；R 4 表示可能被取代的C 1-20 烷氧基、可能被取代的芳氧基、可能被取代的氨基等；X表示氧原子或硫原子）或其盐。
• [EN] METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS<br/>[FR] MÉTHODES POUR LE TRAITEMENT D'INFECTIONS VIRALES À FILOVIRIDAE
  申请人：GILEAD SCIENCES INC

  公开号：WO2016069826A1

  公开（公告）日：2016-05-06

  Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae vims infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula (IV): The compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections.

  提供了一种通过给予公式（IV）中的核糖苷、核糖苷磷酸盐及其前药来治疗Filoviridae病毒感染的化合物、方法和药物组合物。所提供的化合物、组合物和方法特别适用于治疗马尔堡病毒、埃博拉病毒和库埃瓦病毒感染。
• [EN] DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES<br/>[FR] DÉSAMINATION DE NUCLÉOSIDES ORGANOPHOSPHORÉS
  申请人：INST UNIV DE CIÈNCIA I TECNOLOGIA S A

  公开号：WO2016146808A1

  公开（公告）日：2016-09-22

  The invention relates to a new synthethic process for obtaining compounds of formula (I) from compounds of formula (II) by means of cytidine deaminase enzymes.

  这项发明涉及一种新的合成过程，通过胞嘧啶脱氨酶酶将式(I)化合物从式(II)化合物中获得。
• [EN] NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES<br/>[FR] DÉRIVÉS DE NICOTINAMIDE MONONUCLÉOTIDE ET LEUR UTILISATIONS
  申请人：METROBIOTECH LLC

  公开号：WO2017024255A1

  公开（公告）日：2017-02-09

  The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for treating diseases and improving cell and tissue survival.

  本发明涉及烟酰胺单核苷酸衍生物的组合物及其使用方法。本发明还涉及制备烟酰胺单核苷酸衍生物的方法。本发明涉及含有烟酰胺单核苷酸衍生物的药物组合物和营养补充剂。本发明涉及使用烟酰胺单核苷酸衍生物的方法，促进细胞和组织中烟酰胺腺嘌呤二核苷酸（NAD+）水平的增加，用于治疗疾病和改善细胞和组织的存活。
• [EN] NUCLEOTIDES FOR THE TREATMENT OF CANCER<br/>[FR] NUCLÉOTIDES POUR LE TRAITEMENT DU CANCER
  申请人：IDENIX PHARMACEUTICALS LLC

  公开号：WO2016189055A1

  公开（公告）日：2016-12-01

  The present application relates to novel nucleoside derivatives of formula (I) as claimed in claim 1, pharmaceutical compositions comprising the compounds, processes of preparation thereof, and methods of use thereof for treating cancer.

  本申请涉及公式（I）中所要求的新型核苷酸衍生物，其中包括该化合物的制药组合物、制备过程以及用于治疗癌症的使用方法。